Short Interest Surges for Fulcrum and MillerKnoll Amid Market Shifts
Recent short interest updates for Fulcrum Therapeutics and MillerKnoll signal growing investor caution as both companies navigate critical operational and macroeconomic challenges. While Fulcrum faces clinical-stage volatility following in-line earnings, MillerKnoll contends with a Hold consensus and broader pressure on the office furniture sector.